Cargando…

The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project

This commentary describes the progress of the SEAL [Surrogate Endpoints for Aggressive Lymphoma] research group and invites collaboration in sharing data to continue building a large database of individual patient data from multiple clinical trials in DLBCL.

Detalles Bibliográficos
Autores principales: Sargent, Daniel J., Shi, Qian, Flowers, Christopher R., Schmitz, Norbert, Habermann, Thomas M., Flament, Jocelyne, Fu, Tommy, Coiffier, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728027/
https://www.ncbi.nlm.nih.gov/pubmed/28798271
http://dx.doi.org/10.1634/theoncologist.2017-0177
_version_ 1783285997289603072
author Sargent, Daniel J.
Shi, Qian
Flowers, Christopher R.
Schmitz, Norbert
Habermann, Thomas M.
Flament, Jocelyne
Fu, Tommy
Coiffier, Bertrand
author_facet Sargent, Daniel J.
Shi, Qian
Flowers, Christopher R.
Schmitz, Norbert
Habermann, Thomas M.
Flament, Jocelyne
Fu, Tommy
Coiffier, Bertrand
author_sort Sargent, Daniel J.
collection PubMed
description This commentary describes the progress of the SEAL [Surrogate Endpoints for Aggressive Lymphoma] research group and invites collaboration in sharing data to continue building a large database of individual patient data from multiple clinical trials in DLBCL.
format Online
Article
Text
id pubmed-5728027
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-57280272017-12-17 The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project Sargent, Daniel J. Shi, Qian Flowers, Christopher R. Schmitz, Norbert Habermann, Thomas M. Flament, Jocelyne Fu, Tommy Coiffier, Bertrand Oncologist Commentaries This commentary describes the progress of the SEAL [Surrogate Endpoints for Aggressive Lymphoma] research group and invites collaboration in sharing data to continue building a large database of individual patient data from multiple clinical trials in DLBCL. AlphaMed Press 2017-08-10 2017-12 /pmc/articles/PMC5728027/ /pubmed/28798271 http://dx.doi.org/10.1634/theoncologist.2017-0177 Text en © AlphaMed Press 2017
spellingShingle Commentaries
Sargent, Daniel J.
Shi, Qian
Flowers, Christopher R.
Schmitz, Norbert
Habermann, Thomas M.
Flament, Jocelyne
Fu, Tommy
Coiffier, Bertrand
The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
title The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
title_full The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
title_fullStr The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
title_full_unstemmed The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
title_short The Search for Surrogate Endpoints in Trials in Diffuse Large B‐Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project
title_sort search for surrogate endpoints in trials in diffuse large b‐cell lymphoma: the surrogate endpoints for aggressive lymphoma project
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728027/
https://www.ncbi.nlm.nih.gov/pubmed/28798271
http://dx.doi.org/10.1634/theoncologist.2017-0177
work_keys_str_mv AT sargentdanielj thesearchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT shiqian thesearchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT flowerschristopherr thesearchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT schmitznorbert thesearchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT habermannthomasm thesearchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT flamentjocelyne thesearchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT futommy thesearchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT coiffierbertrand thesearchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT thesearchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT sargentdanielj searchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT shiqian searchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT flowerschristopherr searchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT schmitznorbert searchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT habermannthomasm searchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT flamentjocelyne searchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT futommy searchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT coiffierbertrand searchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject
AT searchforsurrogateendpointsintrialsindiffuselargebcelllymphomathesurrogateendpointsforaggressivelymphomaproject